Prothena is a clinical-stage neuroscience company focused on the discovery and development of novel therapies with the potential to fundamentally change the course of devastating neurological disorders.
View all
Voyager Therapeutics
Cambridge, United States · Post IPO Equity
Flow Robotics
Copenhagen, Denmark
Exicure
Skokie, United States · Post IPO Equity
NMD Pharma
Aarhus, Denmark
AllStripes
San Francisco, United States · Series B
Korro Bio
Cambridge, United States · Series B
Sutro Biopharma
South San Francisco, United States · Post IPO Equity
Illumina
San Diego, United States
MassBio
Cambridge, United States
DBV Technologies
Montrouge, France · Post IPO Equity
F2G
Manchester, United Kingdom · Private Equity
Alkermes
Dublin 4, Ireland · Post IPO Equity